Search research articles
Contact Us
Filters
Showing results (741-750 of 753) with videos related to
Page
of 76
Sort By:
Proceedings of the National Academy of Sciences of the United States of America
|
June 24, 1998
Identification of novel susceptibility loci for inflammatory bowel disease on chromosomes 1p, 3q, and 4q: evidence for epistasis between 1p and IBD1
J H Cho, D L Nicolae, L H Gold, et al.
Plastic and Reconstructive Surgery. Global Open
|
June 1, 2022
Collagenase Clostridium Histolyticum-aaes for Treatment of Cellulite: A Pooled Analysis of Two Phase-3 Trials
Lawrence S Bass, Joely Kaufman-Janette, John H Joseph, et al.
Dermatologic Surgery : Official Publication for American Society for Dermatologic Surgery [Et Al.]
|
April 12, 2021
Collagenase Clostridium Histolyticum-aaes for the Treatment of Cellulite in Women: Results From Two Phase 3 Randomized, Placebo-Controlled Trials
Joely Kaufman-Janette, John H Joseph, Michael S Kaminer, et al.
Plos One
|
December 22, 2025
Effects of combination therapy of a CDK4/6 and MEK inhibitor in diffuse midline glioma preclinical models
Yusuke Tomita, Gabrielle Link, Yi Ge, et al.
Bioorganic & Medicinal Chemistry Letters
|
April 7, 2009
Synthesis and SAR of tolylamine 5-HT6 antagonists
Jamie M Singer, Michael W Wilson, Paul D Johnson, et al.
Pediatric Blood & Cancer
|
September 22, 2016
Eliciting the child's voice in adverse event reporting in oncology trials: Cognitive interview findings from the Pediatric Patient-Reported Outcomes version of the Common Terminology Criteria for Adverse Events initiative
Bryce B Reeve, Molly McFatrich, Laura C Pinheiro, et al.
Science Translational Medicine
|
October 8, 2010
Effects of AIN457, a fully human antibody to interleukin-17A, on psoriasis, rheumatoid arthritis, and uveitis
Wolfgang Hueber, Dhavalkumar D Patel, Thaddeus Dryja, et al.
Journal of Drugs in Dermatology : JDD
|
September 21, 2018
Once-Daily Oral Sarecycline 1.5 mg/kg/day Is Effective for Moderate to Severe Acne Vulgaris: Results from Two Identically Designed, Phase 3, Randomized, Double-Blind Clinical Trials
Angela Moore, Lawrence J Green, Suzanne Bruce, et al.
The New England Journal of Medicine
|
August 13, 2016
Two Phase 3 Trials of Adalimumab for Hidradenitis Suppurativa
Alexa B Kimball, Martin M Okun, David A Williams, et al.
Journal of Drugs in Dermatology : JDD
|
February 21, 2006
The use of photodynamic therapy in dermatology: results of a consensus conference
Mark S Nestor, Michael H Gold, Arielle N B Kauvar, et al.
Page
of 76
Search research articles
Search
Showing results (741-750 of 753) with videos related to
Sort By:
Page
of 76
Proceedings of the National Academy of Sciences of the United States of America
|
June 24, 1998
Identification of novel susceptibility loci for inflammatory bowel disease on chromosomes 1p, 3q, and 4q: evidence for epistasis between 1p and IBD1
J H Cho, D L Nicolae, L H Gold, et al.
Plastic and Reconstructive Surgery. Global Open
|
June 1, 2022
Collagenase Clostridium Histolyticum-aaes for Treatment of Cellulite: A Pooled Analysis of Two Phase-3 Trials
Lawrence S Bass, Joely Kaufman-Janette, John H Joseph, et al.
Dermatologic Surgery : Official Publication for American Society for Dermatologic Surgery [Et Al.]
|
April 12, 2021
Collagenase Clostridium Histolyticum-aaes for the Treatment of Cellulite in Women: Results From Two Phase 3 Randomized, Placebo-Controlled Trials
Joely Kaufman-Janette, John H Joseph, Michael S Kaminer, et al.
Plos One
|
December 22, 2025
Effects of combination therapy of a CDK4/6 and MEK inhibitor in diffuse midline glioma preclinical models
Yusuke Tomita, Gabrielle Link, Yi Ge, et al.
Bioorganic & Medicinal Chemistry Letters
|
April 7, 2009
Synthesis and SAR of tolylamine 5-HT6 antagonists
Jamie M Singer, Michael W Wilson, Paul D Johnson, et al.
Pediatric Blood & Cancer
|
September 22, 2016
Eliciting the child's voice in adverse event reporting in oncology trials: Cognitive interview findings from the Pediatric Patient-Reported Outcomes version of the Common Terminology Criteria for Adverse Events initiative
Bryce B Reeve, Molly McFatrich, Laura C Pinheiro, et al.
Science Translational Medicine
|
October 8, 2010
Effects of AIN457, a fully human antibody to interleukin-17A, on psoriasis, rheumatoid arthritis, and uveitis
Wolfgang Hueber, Dhavalkumar D Patel, Thaddeus Dryja, et al.
Journal of Drugs in Dermatology : JDD
|
September 21, 2018
Once-Daily Oral Sarecycline 1.5 mg/kg/day Is Effective for Moderate to Severe Acne Vulgaris: Results from Two Identically Designed, Phase 3, Randomized, Double-Blind Clinical Trials
Angela Moore, Lawrence J Green, Suzanne Bruce, et al.
The New England Journal of Medicine
|
August 13, 2016
Two Phase 3 Trials of Adalimumab for Hidradenitis Suppurativa
Alexa B Kimball, Martin M Okun, David A Williams, et al.
Journal of Drugs in Dermatology : JDD
|
February 21, 2006
The use of photodynamic therapy in dermatology: results of a consensus conference
Mark S Nestor, Michael H Gold, Arielle N B Kauvar, et al.
Page
of 76